AB-FUBINACA, A SYNTHETIC CANNABINOID IN â€œFUNKY GREEN STUFFâ„¢â€
Objective: The objective of this research was to isolate and identify any potential synthetic cannabinoids disguised in the commercially available claimed-to-be herbal scent, known as â€œFunky Green Stuffâ„¢â€.
Methods: Potential synthetic cannabinoids were extracted via percolating the content of the commercial herbal scent bag â€œFunky Green StuffTMâ€ in methanol. Column chromatographic isolation afforded one main pure compound. Different spectral analyses established the identity of the isolated compound.
Results: Chromatographic purification afforded 372 mg (5.2% w/w enrichment ratio) of pure needle crystals. Spectral analyses revealed the identity of the isolated compound as the synthetic cannabinoid AB-FUBINACA, confirming the assumption that a synthetic cannabinoid was disguised as an herbal scent product.
Conclusion: Several scent herbal products, also known as â€œspiceâ€, are used to disguise synthetic cannabinoids. Their detection proved to be troublesome since authentic standards are not yet available. The synthetic cannabinoid, AB-FUBINACA, was isolated from one of these products, and its identity was established based on its spectral data.
2. Schmidt M, Sharma A, Schifano F, Feinmannn C. â€œLegal highsâ€ on the net-Evaluation of UK-based Websites, products and product information. Forensic Sci Int 2011;206:92-7.
3. AuwÓ“rter V, Dresen S, Weinmann W, MÃ¼ller M, PÃ¼tz, Ferreiros N. Spice and other herbal blends: Harmless incense or cannabinoid designer drugs? J Mass Spectrom 2009;44:832-7.
4. Compton D, Rice K, De Costa B, Razdan R, Melvin L, Johnson M, et al. Cannabinoid structureâ€activity relationships: Correlation of receptor binding and in vivo activities. J pharmacol Exp Ther 1993;265:218â€26.
5. Porter A, Felder C. The endocannabinoid nervous system: Unique opportunities for therapeutic intervention. Pharmacol Ther 2009;90:45â€60.
6. European Monitoring Centre for Drugs and Drug Addiction. Understanding the â€œSpiceâ€ Phenomenon. Luxembourg: Office for Official Publications of the European Communities; 2009. p. 1-34.
7. Robinson L, Goonawardena AV, Pertwee R, Hampson RE, Platt B, Riedel G. Win 55,212-2 induced deficits in spatial learning are mediated by cholinergic hypofunction. Behav Brain Res 2010;208:584-92.
8. De Brabanter N, Deventera K, Stoveb V, Van Eenooa P. Synthetic cannabinoids: General considerations. Proc Belgian Royal Acad Med 2013;2:209-25.
9. United Nations Office on Drugs and Crime. Recommended methods for the identification and analysis of synthetic cannabinoid receptor agonists in seized materials. Vienna: United Nations Office, Publishing and Library Section; 2013. p. 1-56.
10. Schneir A, Cullen J, Binh T. â€œSpiceâ€ girls: synthetic cannabinoid intoxication. J Emerg Med 2011;40:296-9.
11. Steup C. Untersuchung des Handelsproduktes â€œSpiceâ€. THC Pharm GmbH 2008.
12. Vardakou I, Pistos C, Spiliopoulou C. Spice drugs as a new trend: Mode of action, identification, and legislation. Toxicol Lett 2010;197:157-62.
13. Uchiyama N, Kawamura M, Kikura-Hanajari R, Goda Y. Identification and quantitation of two cannabimimetic phenylacetylindoles JWH-251 and JWH-250, and four cannabimimetic naphthoylindoles JWH-081, JWH-015, JWH-200, and JWH-073 as designer drugs in illegal products. Forensic Toxicol 2010;29:25-37.
14. United Nations Office on Drugs and Crime. Synthetic cannabinoids in herbal products. Vienna: United Nations Office, Publishing and Library Section; 2011. p. 1-24.
15. Teske J, Weller J, Fieguth A, RothÃ¤mel T, Schulz Y, TrÃ¶ger H. Sensitive and rapid quantification of the cannabinoid receptor agonist naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in human serum by liquid chromatographyâ€“tandem mass spectrometry. J Chromatogr B: Anal Technol Biomed Life Sci 2010;878:2659-63.
16. Sobolevsky T, Prasolov I, Rodchenkov G. Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids. Drug Test Anal 2012;4:745-53.
17. Kim U, Jin M, Lee J, Han S, In M, Yoo H. Tentative identification of phase I metabolites of HU-210, a classical synthetic cannabinoid, by LCâ€“MS/MS. J Pharm Biomed Anal 2012;64-65:26-34.
18. Zhang Q, Ma P, Cole R, Wang G. Identification of in vitro metabolites of JWH-015, an aminoalkylindole agonist for the peripheral cannabinoid receptor (CB2) by HPLC-MS/MS. Anal Bioanal Chem 2006;386:1345-55.
19. Lindigkeit R, Boehme A, Eiserloh I, Luebbecke M, Wiggermann M, Ernst L, et al. Spice: a never ending story? Forensic Sci Int 2009;191:58-63.
20. Schifano F, Corazza O, Deluca P, Davey Z, Di Furia L, Farre M, et al. Psychoactive drug or mystical incense? Overview of the online available information on spice products. Int J Culture Mental Health 2009;2:137-44.
21. Uchiyama N, Matsuda S, Wakana D, Kikura-Hanajiri R, Goda Y. New cannabimimetic indazole derivatives, N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) and N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) identified as designer drugs in illegal products. Forensic Toxicol 2012;31:93-100.
22. Behonick G, Shanks K, Firchau D, Mathur G, Lynch C, Nashelsky M, et al. Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5F-PB-22. J Anal Toxicol 2014;38:559-62.